News

Sign up now to hear Dr. Abaid speak October 29, 6pm

Patient-Focused Webinar On Paclitaxel/Carboplatin

The Foundation for Women's Cancer (FWC) hosted a webinar on Oct. 24 titled, You Got This: Getting Prepared for Paclitaxel/Carboplatin Chemotherapy. This patient-focused webinar covered how these chemotherapy drugs work; what to expect on the first day of treatment and their progress; tips and strategies to help prepare for chemotherapy treatment; and the onset and duration of side effects, and when to call their doctor. Speakers included Judith A. Smith, PharmD, BCOP, CPHQ, FCCP, FISOPP; Rebecca A. Brooks, MD and Kim Hurley—an ovarian cancer survivor whose paclitaxel/carboplatin chemotherapy treatment lasted for seven months. Click here to watch.

FDA grants priority review to olaparib for maintenance therapy of BRCA-positive ovarian cancer

The FDA granted priority review to a supplemental new drug application that seeks approval of olaparib tablets for maintenance therapy of women with newly diagnosed BRCA-mutated advanced ovarian cancer. The designation applies to use of the agent for women who are in complete or partial response after first-line standard platinum-based chemotherapy. The FDA is expected to make a decision on the application in the first quarter of 2019. Click here to read more.

A Comprehensive Approach to Gynecologic Cancer Care

Dr. Lisa Abaid is Named Co-Director of High-Risk Breast & Ovarian Cancer Program

HPV vaccination and regular Pap screenings can greatly reduce risk of cervical cancer

Dr. Abaid discusses Genetic Screening

St. Jude Welcomes Back GOA Staff!

Congrats Dr. Lisa Abaid on the 10,000th Robotic Surgery

Copyright © 2019 Optimized360 LLC | All Rights Reserved | Privacy Policy | Terms of Use | Disclaimer